Hospital-based Diabetes Prevention Study in Korea

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 744 participants.

Also called NCT02981121

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 744 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02981121
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02981121. Randomized; no masking; primary purpose prevention. Start 2016-11 (registry gives no type); primary completion 2019-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hospital-based Diabetes Prevention Study in Korea
Condition
PreDiabetes
Intervention (Behavioral)
Exercise and Diet remedies
Intervention (Drug)
Metformin
Lead sponsor
Jeong-taek Woo (class: other)
Collaborator
National Evidence-Based Healthcare Collaborating Agency (class: other government)
Collaborator
Kyungpook National University Hospital (class: other)
Collaborator
Korea University Guro Hospital (class: other)
Collaborator
Pusan National University Hospital (class: other)
Collaborator
Samsung Medical Center (class: other)
Collaborator
Seoul National University Hospital (class: other)
Collaborator
Asan Medical Center (class: other)
Collaborator
Ajou University School of Medicine (class: other)
Collaborator
Severance Hospital (class: other)
Collaborator
Chonbuk National University Hospital (class: other)

Record details

Record id
cardio:ct-nct02981121
Content hash
b6ee6643c1a8d7aa9653d62de51db6d0d9f65a97dbb85279f51cc96aec946bc4